According to the recently-published report by Persistence Market Research, the global market for gene expression analysis will reflect a steady growth during the forecast period, 2017-2022.
By the end of 2022, the global gene expression analysis market is predicted to surpass US$ 4,500 Mn valuation, reflecting a robust CAGR in terms of revenues. The study throws a light on various factors influence the dynamics of global gene expression analysis market, and offers insightful projections, the highlights of which are mentioned below.
Get Sample Copy Of This Report @ https://www.persistencemarketresearch.com/samples/18085
Gene Expression Analysis Market: Regional Forecast
Through 2022, North America is anticipated to hold a leading position in the global market for gene expression analysis. Most of the companies operating in the expansion of global gene expression analysis market are based in the US. Moreover, North American research institutes contributing to the field of functional genomics continue to support the development of new drugs derived from gene expression analysis studies. Drug discovery is a key application of gene expression analysis, and the US healthcare markets are observed as lucrative grounds for players in the global gene expression analysis market.
- North America’s gene expression analysis market is pegged to be reach a billion dollar valuation by the end of 2017. The report projects that throughout the forecast period, the gene expression analysis market in North America will reflect a robust CAGR, wherein the US market will be observed as the largest contributor to this growth.
- Europe is also expected to reflect impressive growth as the gene expression analysis market in this region is poised to create an incremental opportunity of over US$ 200 Mn between 2017 and 2022.
- The gene expression analysis market in Asia-Pacific excluding Japan (APEJ) region is anticipated to record fastest growth. To the contrary, Japan’s gene expression analysis market is expected to reflect lowest CAGR during the forecast period.
Widespread Adoption of Northern Blotting Technology
On the basis of technology, the report projects that northern blotting will be at the forefront of adoption, and will reflect highest share on global revenues of gene expression analysis market. DNA microarrays and PCR techniques are also projected to gain traction as preferred technologies used for synthesizing functional gene products through gene expression analysis. Advancements in RNA-sequencing, 2-D gel electrophoresis, western blotting, immunoassays, ChIP, mass spectrometry and other technologies are also expected to influence the future prospects of global gene expression analysis market.
The report further projects that gene expression analysis will find higher traction in drug discovery & development applications. Towards the end of the forecast period, application of gene expression analysis in drug discovery & development is anticipated to procure over US$ 1,200 Mn in global revenues. Concurrently, the demand for gene expression analysis products with low- to mid- plex capacity will also witness considerable uptake during the forecast period. The report also anticipates that sales of products – kits & reagents – will reflect a sizeable share on the value of global gene expression analysis market throughout the forecast period. By the end of 2022, kits & reagents will register over one-third share on the global market revenues for gene expression analysis.
Request For Customization @ https://www.persistencemarketresearch.com/request-customization/18085
The report has also profiled key players in the global market for gene expression analysis, which include Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., General Electric Company, Luminex Corporation, Illumina, Inc., Oxford Gene Technology IP, PerkinElmer, Inc., QIAGEN NV, Roche Holding AG, and Thermo Fisher Scientific, Inc.